Literature DB >> 17405121

The non-Hodgkin lymphomas: a review of the epidemiologic literature.

Dominik D Alexander1, Pamela J Mink, Hans-Olov Adami, Ellen T Chang, Philip Cole, Jack S Mandel, Dimitrios Trichopoulos.   

Abstract

The non-Hodgkin lymphomas (NHL) are a heterogeneous group of B-cell and T-cell neoplasms that arise primarily in the lymph nodes. NHL incidence rates in the US doubled between about 1970 and 1990, and stabilized during the 1990s. NHL accounts for approximately 3.4% of cancer deaths in the US. Although some of the observed patterns in NHL have been related to HIV/AIDS, these conditions cannot fully explain the magnitude of the changes; neither do changes in classification systems nor improved diagnostic capabilities. Studies of occupational and environmental exposures (e.g., pesticides, solvents) have produced no consistent pattern of significant positive associations. Inverse associations with ultraviolet radiation exposure and alcohol and fish intake, and positive associations with meat and saturated fat intake have been reported in several studies; additional studies are needed to confirm or refute these associations. Family history of NHL or other hematolympho-proliferative cancers and personal history of several autoimmune disorders are associated with increased risk of NHL, but are not likely to account for a large proportion of cases. HIV and other infectious agents, such as human herpesvirus 8 and Epstein-Barr, appear to be associated with differing types of NHL, such as some B-cell lymphomas. Future epidemiologic studies should evaluate associations by NHL type, enhance exposure information collected, and elucidate factors that may identify susceptible (or resistant) subpopulations because of genetic, immunologic or other characteristics. The extent to which the etiology of NHL types may differ is important to resolve in ongoing and future studies.

Entities:  

Mesh:

Year:  2007        PMID: 17405121     DOI: 10.1002/ijc.22719

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  135 in total

Review 1.  Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma.

Authors:  Catarina Dias; David A Isenberg
Journal:  Nat Rev Rheumatol       Date:  2011-06       Impact factor: 20.543

2.  Non-Hodgkin lymphoma in early life.

Authors:  Benjamin Emmanuel; William F Anderson
Journal:  J Natl Cancer Inst       Date:  2012-05-22       Impact factor: 13.506

3.  A case-control study of tobacco use and other non-occupational risk factors for lymphoma subtypes defined by t(14; 18) translocations and bcl-2 expression.

Authors:  Cindy M Chang; Jane C Schroeder; Andrew F Olshan; Cherie H Dunphy; Wen-Yi Huang; Ralph S Baric; Kathleen Conway; James R Cerhan; Charles F Lynch; Nathaniel Rothman; Kenneth P Cantor; Aaron Blair
Journal:  Cancer Causes Control       Date:  2010-03-16       Impact factor: 2.506

4.  Racial differences in chronic immune stimulatory conditions and risk of non-Hodgkin's lymphoma in veterans from the United States.

Authors:  Jill Koshiol; Tram Kim Lam; Gloria Gridley; David Check; Linda Morris Brown; Ola Landgren
Journal:  J Clin Oncol       Date:  2010-12-20       Impact factor: 44.544

5.  Genetic polymorphisms in IL10RA and TNF modify the association between blood transfusion and risk of non-Hodgkin lymphoma.

Authors:  Xiaofeng Bi; Tongzhang Zheng; Qing Lan; Zhijian Xu; Yingtai Chen; Gongjian Zhu; Francine Foss; Christopher Kim; Min Dai; Ping Zhao; Theodore Holford; Brian Leaderer; Peter Boyle; Qian Deng; Stephen J Chanock; Nathaniel Rothman; Yawei Zhang
Journal:  Am J Hematol       Date:  2012-05-31       Impact factor: 10.047

6.  A prospective analysis of blood donation history and risk of non-Hodgkin lymphoma.

Authors:  Kazusa Ishii; Brenda M Birmann; Xuehong Zhang; Edward Giovannucci; Kimberly A Bertrand
Journal:  Leuk Lymphoma       Date:  2015-10-16

7.  The serine-threonine kinase p90RSK is a new target of enzastaurin in follicular lymphoma cells.

Authors:  S Kheirallah; S Fruchon; L Ysebaert; A Blanc; F Capilla; A Marrot; T Alsaati; F X Frenois; K A Benhadji; J J Fournié; G Laurent; C Bezombes
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

8.  Gene delivery in malignant B cells using the combination of lentiviruses conjugated to anti-transferrin receptor antibodies and an immunoglobulin promoter.

Authors:  Lai Sum Leoh; Kouki Morizono; Kathleen M Kershaw; Irvin S Y Chen; Manuel L Penichet; Tracy R Daniels-Wells
Journal:  J Gene Med       Date:  2014 Jan-Feb       Impact factor: 4.565

9.  Solvent exposure and non-Hodgkin lymphoma: no risk in a population-based study in the San Francisco Bay Area.

Authors:  Gregory J Tranah; Elizabeth A Holly; Paige M Bracci
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11       Impact factor: 4.254

10.  Genetic variation in tumor necrosis factor and the nuclear factor-kappaB canonical pathway and risk of non-Hodgkin's lymphoma.

Authors:  James R Cerhan; Wen Liu-Mares; Zachary S Fredericksen; Anne J Novak; Julie M Cunningham; Neil E Kay; Ahmet Dogan; Mark Liebow; Alice H Wang; Timothy G Call; Thomas M Habermann; Stephen M Ansell; Susan L Slager
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.